P7M

N-[(5-bromothiophen-2-yl)sulfonyl]-2,4-dichlorobenzamide

Created:	2019-08-05
Last modified:	2021-03-01

Find Related PDB Entry
1 entries where P7M is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	26
Chiral Atom Count	0
Bond Count	27
Aromatic Bond Count	11

2D diagram of P7M

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-[(5-bromothiophen-2-yl)sulfonyl]-2,4-dichlorobenzamide
Synonyms	Tasisulam
Systematic Name (OpenEye OEToolkits)	~{N}-(5-bromanylthiophen-2-yl)sulfonyl-2,4-bis(chloranyl)benzamide
Formula	C₁₁ H₆ Br Cl₂ N O₃ S₂
Molecular Weight	415.11
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	c1c(Cl)ccc(c1Cl)C(=O)NS(c2sc(cc2)Br)(=O)=O
SMILES	CACTVS	3.385	Clc1ccc(c(Cl)c1)C(=O)N[S](=O)(=O)c2sc(Br)cc2
SMILES	OpenEye OEToolkits	2.0.7	c1cc(c(cc1Cl)Cl)C(=O)NS(=O)(=O)c2ccc(s2)Br
Canonical SMILES	CACTVS	3.385	Clc1ccc(c(Cl)c1)C(=O)N[S](=O)(=O)c2sc(Br)cc2
Canonical SMILES	OpenEye OEToolkits	2.0.7	c1cc(c(cc1Cl)Cl)C(=O)NS(=O)(=O)c2ccc(s2)Br
InChI	InChI	1.03	InChI=1S/C11H6BrCl2NO3S2/c12-9-3-4-10(19-9)20(17,18)15-11(16)7-2-1-6(13)5-8(7)14/h1-5H,(H,15,16)
InChIKey	InChI	1.03	WWONFUQGBVOKOF-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB11941
Name	Tasisulam
Groups	investigational
Description	Tasisulam has been used in trials studying the treatment and basic science of Melanoma, Lymphoma, Solid Tumors, Breast Cancer, and Ovarian Cancer, among others.
Synonyms	LY573636 Tasisulam Sodium Tasisulam
Categories	Acids, Carbocyclic Amides Benzene Derivatives Benzoates Sulfones Sulfur Compounds
CAS number	519055-62-0

Related Resource References

Resource Name	Reference
PubChem	10160238
ChEMBL	CHEMBL2110587

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.